Related Experiment Video

Updated: Oct 15, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

Specific therapies proposed for the management of COVID-19

Oscar Olvera-Reyes1, J Jesús Horacio Ábrego-Lara1, Gregorio Iván Rodríguez-Hernández1

  • 1Instituto Mexicano del Seguro Social, Centro Médico Nacional del Bajío, Hospital de Especialidades No. 1, Servicio de Medicina Interna. Léon, Guanajuato, México.

Revista Medica Del Instituto Mexicano Del Seguro Social
|October 25, 2021
PubMed

Insights

This review summarizes current coronavirus treatments, detailing their antiviral properties and adverse effects. Ongoing research is crucial for developing effective therapies against this global health challenge.

Area of Science:

  • * Virology and infectious diseases.
  • * Global public health and epidemiology.
  • * Pharmacology and therapeutics.

Background:

  • * The emergence of a novel coronavirus has overwhelmed global health systems, necessitating urgent therapeutic strategies.
  • * Extensive research and clinical trials have been conducted to find effective treatments and management protocols.
  • * The need for accessible summaries of emerging evidence on coronavirus therapies is critical for healthcare professionals and researchers.

Purpose of the Study:

  • * To consolidate and present a summary of various investigated therapies for the novel coronavirus.
  • * To detail the antiviral efficacy and potential adverse effects of each studied treatment.
  • * To aid readers in understanding the current landscape of coronavirus therapeutic research.

Main Methods:

  • * Comprehensive review of existing scientific literature and clinical trial data.
  • * Systematic collation of information on antiviral mechanisms and documented side effects.
  • * Synthesis of findings to provide a concise overview of therapeutic options.

Main Results:

  • * Multiple therapeutic agents have been evaluated for their potential against the novel coronavirus.
  • * Reported antiviral activities vary among different treatments.
  • * Adverse effect profiles differ significantly across the studied therapies.

Conclusions:

  • * The current review provides a summary of investigated coronavirus treatments, highlighting their benefits and risks.
  • * Further research is essential to resolve existing uncertainties and advance therapeutic development.
  • * The field of coronavirus treatment is rapidly evolving, with new knowledge continuously emerging.
Keywords:
Coronavirus InfectionsDexamethasoneDrug TherapyPandemicsSARS-CoV-2

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.4K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
499
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.8K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
49
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
487
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
233